Aktiesnakken — Juni 2012
-
ja efter vores q&a
-
men rygterne er også at ingen forstod hvorfor Genmab ikke hoppede mere på de dara data, som vel cementerer en høj sandsynlighed for en deal
-
den er jo steget fra 42,8 og så hverdag i 4-5 dage
-
vi jokede lidt om 47 så sent som igår. Nu er den blæst af banen
-
måske er der kommet rygter om salgstal fra receptdatabasen?
-
det fedeste ville stadig være 1) dara aftale 50-100 mill upfront 2) salg af fabrik 3)Arzerra salg med lidt hockey stick
-
I dollar yep
-
ja Plex. det ville være fedt
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind